BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 36585301)

  • 1. Repeat hepatectomy versus microwave ablation for solitary and small (≤3 cm) recurrent hepatocellular carcinoma with early or late recurrence: A propensity score matched study.
    Wang WQ; Lv X; Li J; Li J; Wang JL; Yuan T; Liu JJ; Zhu RH; Huang ZY; Zhang EL
    Eur J Surg Oncol; 2023 May; 49(5):1001-1008. PubMed ID: 36585301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver resection versus microwave ablation for solitary and small (≤ 3 cm) HCC with early recurrence in different stages of liver cirrhosis: A propensity score matching study.
    Zhu RH; Huang Z; Xie ZH; Yuan T; Li J; Wang WQ; Lv X; Wang JL; Huang ZY; Zhang EL
    Asian J Surg; 2024 Feb; ():. PubMed ID: 38342723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal treatment strategy for recurrent hepatocellular carcinoma based on recurrence time and tumor size: A propensity score matching study.
    Wan W; Zhang H; Ji T; Zhang L; Luo K; Xiong D
    Clin Res Hepatol Gastroenterol; 2023 Aug; 47(7):102157. PubMed ID: 37321321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transarterial chemoembolization combined with microwave ablation versus microwave ablation only for Barcelona clinic liver cancer Stage B hepatocellular carcinoma: A propensity score matching study.
    Li X; Chen B; An C; Cheng Z; Han Z; Liu F; Yu J; Liang P
    J Cancer Res Ther; 2020 Sep; 16(5):1027-1037. PubMed ID: 33004744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound-guided percutaneous microwave ablation treatment of initial recurrent hepatocellular carcinoma after hepatic resection: long-term outcomes.
    Zhang TT; Luo HC; Cui X; Zhang W; Zhang LY; Chen XP; Li KY
    Ultrasound Med Biol; 2015 Sep; 41(9):2391-9. PubMed ID: 26074453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microwave ablation versus surgical resection for subcapsular hepatocellular carcinoma: a propensity score-matched study of long-term therapeutic outcomes.
    Liu K; Zheng H; Sui X; Liu B; Meng M; Feng Y; Zhu Q; Zhao X
    Eur Radiol; 2023 Mar; 33(3):1938-1948. PubMed ID: 36114849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microwave ablation versus radiofrequency ablation as bridge therapy in potentially transplantable patients with single HCC ≤ 3 cm: A propensity score-matched study.
    Wang X; Yu H; Zhao F; Xu Y; Wang C; Liu K; Liu B; Zheng H; Wei Y; Wang X; Zhu Q; Huang M; Feng Y
    Eur J Radiol; 2023 Jul; 164():110860. PubMed ID: 37178491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeat hepatectomy versus percutaneous ablation for recurrent hepatocellular carcinoma: emphasis on the impact of early or late recurrence.
    Wang C; Li K; Huang Z; Yuan Y; He W; Zheng Y; Zou R; Li B; Yuan Y; Qiu J
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):15113-15125. PubMed ID: 37632543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous microwave ablation versus robot-assisted hepatectomy for early hepatocellular carcinoma: A real-world single-center study.
    Ding W; Yu J; Liu F; Yu X; Cheng Z; Han Z; Liang P
    Dig Liver Dis; 2022 Feb; 54(2):243-250. PubMed ID: 34244109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microwave ablation for peribiliary hepatocellular carcinoma: propensity score analyses of long-term outcomes.
    Hu H; Chi JC; Liu R; Zhai B
    Int J Hyperthermia; 2021; 38(1):191-201. PubMed ID: 33682598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
    Bai XM; Cui M; Yang W; Wang H; Wang S; Zhang ZY; Wu W; Chen MH; Yan K; Goldberg SN
    Radiology; 2021 Aug; 300(2):458-469. PubMed ID: 34003058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microwave ablation versus radiofrequency ablation for subcapsular hepatocellular carcinoma: a propensity score-matched study.
    Zheng H; Liu K; Yang Y; Liu B; Zhao X; Chen Y; Feng Y; Meng M; Tan X; Zhu Q
    Eur Radiol; 2022 Jul; 32(7):4657-4666. PubMed ID: 35092477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.
    Feng Y; Wu H; Huang DQ; Xu C; Zheng H; Maeda M; Zhao X; Wang L; Xiao F; Lv H; Liu T; Qi J; Li J; Zhong N; Wang C; Feng H; Liang B; Ren W; Qin C; Nguyen MH; Zhu Q
    Eur Radiol; 2020 Nov; 30(11):6357-6368. PubMed ID: 32529568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeat hepatectomy versus radiofrequency ablation in management of recurrent hepatocellular carcinoma: an average treatment effect analysis.
    Chua DW; Koh YX; Syn NL; Chuan TY; Yao TJ; Lee SY; Goh BKP; Cheow PC; Chung AY; Chan CY
    Ann Surg Oncol; 2021 Nov; 28(12):7731-7740. PubMed ID: 33969464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival analysis of ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma conforming to the Milan criteria: primary versus recurrent HCC.
    Zhang J; Guo G; Li T; Guo C; Han Y; Zhou X
    Int J Hyperthermia; 2024; 41(1):2318829. PubMed ID: 38467417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study.
    Peng Z; Wei M; Chen S; Lin M; Jiang C; Mei J; Li B; Wang Y; Li J; Xie X; Kuang M
    Eur Radiol; 2018 Aug; 28(8):3522-3531. PubMed ID: 29536241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver resection versus microwave ablation for hepatocellular carcinoma in ideal candidates for ablation per Barcelona Clinic Liver Cancer staging: a propensity score matching and inverse probability of treatment weighting analysis.
    Tong Y; Cai R; Li JX; Chang DH; Wang LZ; Cai WW; Xiao YD
    Aliment Pharmacol Ther; 2022 Dec; 56(11-12):1602-1614. PubMed ID: 36285593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: a propensity score analysis.
    Liu W; Zheng Y; He W; Zou R; Qiu J; Shen J; Yang Z; Zhang Y; Wang C; Wang Y; Zuo D; Li B; Yuan Y
    Aliment Pharmacol Ther; 2018 Sep; 48(6):671-681. PubMed ID: 30063081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anatomic resection versus radiofrequency ablation with an ablative margin ≥ 1.0 cm for solitary small hepatocellular carcinoma measuring ≤ 3 cm: Comparison of long-term outcomes using propensity score matching analysis.
    Zhang C; Gao R; Guo S; Ning C; Li A; Wang X; Li S; Ding J; Kong X; Wang Q; Xu Y; Li J; Gao J; Wang S; Kong J; Ke S; Sun W
    Eur J Radiol; 2022 Oct; 155():110498. PubMed ID: 36049409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeat hepatic resection combined with intraoperative radiofrequency ablation versus repeat hepatic resection alone for recurrent and multiple hepatocellular carcinoma patients meeting the Barcelona Clinic Liver Cancer stage A: A propensity score-matched analysis.
    Huang Y; Xu L; Huang M; Jiang L; Xu M
    Cancer Med; 2023 Apr; 12(8):9213-9227. PubMed ID: 36722129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.